[1]	Cai M, Ni Z, Yuan Z, et al. Past and present:a bibliometric study on polycystic ovary syndrome[J]. J Ovarian Res, 2023, 16(1):42. DOI:10.1186/s13048-022-01072-3. Cited in this article [1]

[2]	Peña AS, Codner E, Witchel S. Criteria for diagnosis of polycystic ovary syndrome during adolescence:literature review[J]. Diagnostics (Basel), 2022, 12(8):1931. DOI:10.3390/diagnostics12081931. Cited in this article [1]

[3]

Bizuneh AD, Joham AE, Teede H, et al. Evaluating the diagnostic accuracy of androgen measurement in polycystic ovary syndrome:a systematic review and diagnostic meta-analysis to inform evidence-based guidelines[J]. Hum Reprod Update, 2025, 31(1):48-63. DOI:10.1093/humupd/dmae028. Cited in this article [1]

[4]	Pace L, Kummer N, Wallace M, et al. The value of androgen measures for diagnosing polycystic ovary syndrome (PCOS) in an unselected population[J]. Reprod Sci, 2025, 32(1):168-175. DOI:10.1007/s43032-024-01702-9. Cited in this article [1]

[5]	朱琴玲, 孙贇. 多囊卵巢综合征内分泌异常的诊治[J]. 中国实用妇科与产科杂志, 2024, 40(6):608-614. DOI:10.19538/j.fk2024060109. Cited in this article [1]

[6]	Li Y, Zhai Y, Li L, et al. Divergent associations between serum androgens and ovarian reserve markers revealed in patients with polycystic ovary syndrome[J]. Front Endocrinol(Lausanne), 2022,13:881740. DOI:10.3389/fendo.2022.88174. Cited in this article [1]

[7]	Cussen L, McDonnell T, Bennett G, et al. Approach to androgen excess in women: Clinical and biochemical insights[J]. Clin Endocrinol(Oxf), 2022, 97(2):174-186. DOI:10.1111/cen.14710. Cited in this article [1]

[8]	Chappell NR, Gibbons WE, Blesson CS. Pathology of hyperandrogenemia in the oocyte of polycystic ovary syndrome[J]. Steroids, 2022,180:108989. DOI:10.1016/j.steroids.2022.108989. Cited in this article [1]

[9]	潘美竹, 张颐. 青春期多囊卵巢综合征患者生活方式的干预对提高生活质量的影响[J]. 中国实用妇科与产科杂志, 2022, 38 (8): 859-861. DOI:10.19538/j.fk2022080123. Cited in this article [2]

[10]	Burghen GA, Givens JR, Kitabchi AE. Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease[J]. J Clin Endocrinol Metab, 1980, 50(1):113-116. DOI:10.1210/jcem-50-1-113. Cited in this article [1]

[11]	Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)[J]. Hum Reprod, 2004, 19(1):41-47. DOI:10.1093/humrep/deh098. Cited in this article [2]

[12]	Wang T, Zhang Z, Qu C, et al. Core fucosylation regulates the ovarian response via FSH receptor during follicular development[J]. J Adv Res, 2025, 67:105-120. DOI:10.1016/j.jare.2024.01.025. Cited in this article [1]

[13]	Fiorentino G, Cimadomo D, Innocenti F, et al. Biomechanical forces and signals operating in the ovary during folliculogenesis and their dysregulation:implications for fertility[J]. Hum Reprod Update, 2023, 29(1):1-23. DOI:10.1093/humupd/dmac031. Cited in this article [1]

[14]	Barnes RB. The pathogenesis of polycystic ovary syndrome: lessons from ovarian stimulation studies[J]. J Endocrinol Invest, 1998, 21(9):567-579. DOI:10.1007/BF03350782. Cited in this article [1]

[15]	Chauvin S, Cohen-Tannoudji J, Guigon CJ. Estradiol signaling at the heart of folliculogenesis:its potential deregulation in human ovarian pathologies[J]. Int J Mol Sci, 2022, 23(1):512. DOI:10.3390/ijms23010512. Cited in this article [1]

[16]	Balen A. The pathophysiology of polycystic ovary syndrome:trying to understand PCOS and its endocrinology[J]. Best Pract Res Clin Obstet Gynaecol, 2004, 18(5):685-706. Cited in this article [1]

[17]	陈咏, 肖玉红, 张倩, 等. 基础窦状卵泡计数对多囊卵巢综合征患者辅助生殖技术后妊娠结局的影响[J]. 中国实用妇科与产科杂志, 2024, 40(11):1125-1129. DOI:10.19538/j.fk2024110115. Cited in this article [1]

[18]	Dunaif A, Segal KR, Futterweit W, et al. Profound peripheral insulin resistance,independent of obesity,in polycystic ovary syndrome[J]. Diabetes, 1989, 38(9):1165-1174. DOI:10.2337/diab.38.9.1165. Cited in this article [1]

[19]	Salley KE, Wickham EP, Cheang KI, et al. Glucose intolerance in polycystic ovary syndrome--a position statement of the androgen excess society[J]. J Clin Endocrinol Metab, 2007, 92(12):4546-4556. DOI:10.1210/jc.2007-1549. Cited in this article [1]

[20]	Feng C, Jin Z, Sun L, et al. Endogenous SHBG levels correlate with that of glucose transporters in insulin resistance model cells[J]. Mol Biol Rep, 2019, 46(5):4953-4965. DOI:10.1007/s11033-019-04946-w. Cited in this article [1]

[21]

Taghibiglou C, Rashid-Kolvear F, Van Iderstine SC, et al. Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance[J]. J Biol Chem, 2002, 277(1):793-803. DOI:10.1074/jbc.M106737200. Cited in this article [1]

[22]	Horvath TL, Garcia-Segura LM, Naftolin F. Control of gonadotropin feedback: the possible role of estrogen-induced hypothalamic synaptic plasticity[J]. Gynecol Endocrinol, 1997, 11(2):139-143. DOI:10.3109/09513599709152525. Cited in this article [1]

[23]	Yurtdaş G, Akdevelioğlu Y. A new approach to polycystic ovary syndrome: the gut microbiota[J]. J Am Coll Nutr, 2020, 39(4):371-382. DOI:10.1080/07315724.2019.1657515. Cited in this article [1]

[24]	朱依敏. 不孕症合并代谢综合征的孕前管理[J]. 中国实用妇科与产科杂志, 2024, 40(6):604-608. DOI:10.19538/j.fk2024060108. Cited in this article [1]

[25]	邱琳, 刘姜伶, 莫蕙, 等. 定坤丹联合屈螺酮炔雌醇片(Ⅱ)治疗多囊卵巢综合征的有效性及安全性:一项开放标签、非随机对照临床研究[J]. 中国实用妇科与产科杂志, 2025, 41(2):234-240. DOI:10.19538/j.fk2025020117. Cited in this article [1]

[26]	叶生琴, 薛原, 赵晨宇, 等. 广东地区不同表型多囊卵巢综合征患者临床特点及代谢特征分析[J]. 中国实用妇科与产科杂志, 2022, 38(10):1020-1023. DOI:10.19538/j.fk2022100115. Cited in this article [1]

[27]	罗璐, 周灿权. 重视控制性卵巢刺激方案的个体化选择[J]. 中国实用妇科与产科杂志, 2025, 41(12):153-1156. DOI:10.19538/j.fk2025120101. Cited in this article [1]